volume 23, issue 3, P625-642 2009
DOI: 10.1016/j.idc.2009.04.008
View full text
Marya D. Zilberberg, Andrew F. Shorr

Abstract: Pulmonologists and intensivists often care for patients at risk for infections caused by both Aspergillus and Candida. Infection with either can lead to severe life-threatening disease, particularly in immunosuppressed patients, with mortality rates for invasive fungal disease often exceeding 30%. For both organisms, multiple diagnostic challenges remain while newer diagnostic modalities are being developed and tested. Fortunately, therapeutic paradigms are shifting, and clinicians have many new agents in thei…

expand abstract